Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 7 Researches
7.6
USERS' SCORE
Good
Based on 3 Reviews
8.5
Supplement Facts
Serving Size: 31 g (about 1 scoop)
Amount Per Serving
%DV
Calories
130
Total Fat
1.5 g
2%
Saturated Fat
1 g
5%
Cholesterol
60 mg
20%
Sodium
130 mg
6%
Total Carbohydrate
4 g
1%
Total Sugars
2 g
Protein
24 g
48%
Calcium
130 mg
10%
Potassium
160 mg
4%
Top Medical Research Studies
8
Riluzole effectively reduces bone pain
We explored whether riluzole could help ease bone pain caused by prostate cancer. Using a mouse model that mimicked human bone cancer pain, we treated some mice with riluzole while others were not.
Our findings indicated that riluzole significantly reduced pain sensitivity without hindering cancer progression or bone health. This treatment seems effective in offering relief from unpleasant pain sensations associated with bone metastases.
Our findings indicated that riluzole significantly reduced pain sensitivity without hindering cancer progression or bone health. This treatment seems effective in offering relief from unpleasant pain sensations associated with bone metastases.
Read More
8
We explored a unique case where a 39-year-old man presented with severe bone pain due to Sjögren's syndrome-related renal issues. He also exhibited symptoms like polydipsia and hypophosphatemic osteomalacia. After one month of potassium, phosphate, vitamin D, and sodium bicarbonate supplements, we observed significant relief in his bone pain, alongside normalized potassium and phosphorus levels. This indicates that potassium intake can play a crucial role in alleviating bone pain linked to kidney dysfunction in autoimmune conditions, such as Sjögren's syndrome.
Read More
7
We explored a unique case of a 22-year-old woman with Sjögren’s syndrome who experienced unexpected symptoms, including severe bone pain and hypokalemic paralysis.
After thorough diagnostics, including serological tests and assessments, she was diagnosed with distal renal tubular acidosis linked to her condition.
An intensive treatment plan focused on stabilizing her potassium levels effectively relieved her symptoms within just two weeks.
This case highlights the importance of recognizing Sjögren's syndrome early, especially in younger patients, and the need for a comprehensive approach to treatment.
After thorough diagnostics, including serological tests and assessments, she was diagnosed with distal renal tubular acidosis linked to her condition.
An intensive treatment plan focused on stabilizing her potassium levels effectively relieved her symptoms within just two weeks.
This case highlights the importance of recognizing Sjögren's syndrome early, especially in younger patients, and the need for a comprehensive approach to treatment.
Read More
Most Useful Reviews
9
No more stomach pains
Sweet, I heard that whey protein is better absorbed, so I'm drinking this. Both my child and I experience bloated stomachs when we consume WPA protein; therefore, we use WPI with this ingredient. I no longer suffer from stomach pains due to its formulation.
Read More
9
Knee pain alleviated
Excellent! The quality is superb, and the ingredients are harmoniously selected. I appreciate the taste and health benefits, along with the effective packaging. This product has significantly diminished the pain in my knee and strengthened my bones. I noticed an impressive improvement after completing a course, as collagen is essential at any age. My knee no longer hurts.
Read More
7.5
Bone health benefits
The protein size is very good, and the dosage is once a week. It helps bolster immunity. The packaging is excellent, and it assists in reducing deficiency. It's beneficial for bone health and is easily absorbed. The quality and composition are excellent, providing much benefit.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 7 Researches
7.6
- All Researches
8
We explored the impact of calcium treatment on bone pain in patients who developed osteomalacia, a condition linked to intravenous iron infusions. Our focus was on a group of 13 patients diagnosed with this condition, who experienced low phosphate levels due to excess fibroblast growth factor 23 (iFGF23) after receiving ferric carboxymaltose (FCM) infusions.
After halting the FCM infusions, these patients were given supportive treatment, which included phosphate, calcium, and active Vitamin D supplementation. We observed improvements in biochemical markers, including increased phosphate levels and reduced pain scores. However, it’s important to note that while calcium was part of the treatment regimen, we could not isolate its specific effects on bone pain from the other supportive measures used.
Ultimately, our findings highlight the importance of monitoring phosphate levels in patients receiving FCM, and stopping these infusions effectively addresses phosphate wasting. Although supportive treatment showed improvements in pain and bone density, the direct impact of calcium on bone pain remains unclear given the combination of treatments involved.
After halting the FCM infusions, these patients were given supportive treatment, which included phosphate, calcium, and active Vitamin D supplementation. We observed improvements in biochemical markers, including increased phosphate levels and reduced pain scores. However, it’s important to note that while calcium was part of the treatment regimen, we could not isolate its specific effects on bone pain from the other supportive measures used.
Ultimately, our findings highlight the importance of monitoring phosphate levels in patients receiving FCM, and stopping these infusions effectively addresses phosphate wasting. Although supportive treatment showed improvements in pain and bone density, the direct impact of calcium on bone pain remains unclear given the combination of treatments involved.
Read More
8
Riluzole effectively reduces bone pain
We explored whether riluzole could help ease bone pain caused by prostate cancer. Using a mouse model that mimicked human bone cancer pain, we treated some mice with riluzole while others were not.
Our findings indicated that riluzole significantly reduced pain sensitivity without hindering cancer progression or bone health. This treatment seems effective in offering relief from unpleasant pain sensations associated with bone metastases.
Our findings indicated that riluzole significantly reduced pain sensitivity without hindering cancer progression or bone health. This treatment seems effective in offering relief from unpleasant pain sensations associated with bone metastases.
Read More
8
We explored a unique case where a 39-year-old man presented with severe bone pain due to Sjögren's syndrome-related renal issues. He also exhibited symptoms like polydipsia and hypophosphatemic osteomalacia. After one month of potassium, phosphate, vitamin D, and sodium bicarbonate supplements, we observed significant relief in his bone pain, alongside normalized potassium and phosphorus levels. This indicates that potassium intake can play a crucial role in alleviating bone pain linked to kidney dysfunction in autoimmune conditions, such as Sjögren's syndrome.
Read More
8
We examined the effects of low-dose adefovir therapy on bone pain in patients showing signs of nephrogenic hypophosphatemic osteomalacia. Over two years, five patients developed reduced phosphate levels and renal issues, leading to bone pain. After stopping the treatment and providing phosphate and potassium supplements, we noticed significant decreases in bone pain and improved mobility in some patients. This indicates that potassium treatment, alongside phosphate supplementation, can positively affect bone pain related to kidney issues stemming from adefovir.
Read More
7
We explored a unique case of a 22-year-old woman with Sjögren’s syndrome who experienced unexpected symptoms, including severe bone pain and hypokalemic paralysis.
After thorough diagnostics, including serological tests and assessments, she was diagnosed with distal renal tubular acidosis linked to her condition.
An intensive treatment plan focused on stabilizing her potassium levels effectively relieved her symptoms within just two weeks.
This case highlights the importance of recognizing Sjögren's syndrome early, especially in younger patients, and the need for a comprehensive approach to treatment.
After thorough diagnostics, including serological tests and assessments, she was diagnosed with distal renal tubular acidosis linked to her condition.
An intensive treatment plan focused on stabilizing her potassium levels effectively relieved her symptoms within just two weeks.
This case highlights the importance of recognizing Sjögren's syndrome early, especially in younger patients, and the need for a comprehensive approach to treatment.
Read More
User Reviews
USERS' SCORE
Good
Based on 3 Reviews
8.5
- All Reviews
- Positive Reviews
- Negative Reviews
9
No more stomach pains
Sweet, I heard that whey protein is better absorbed, so I'm drinking this. Both my child and I experience bloated stomachs when we consume WPA protein; therefore, we use WPI with this ingredient. I no longer suffer from stomach pains due to its formulation.
Read More
9
Knee pain alleviated
Excellent! The quality is superb, and the ingredients are harmoniously selected. I appreciate the taste and health benefits, along with the effective packaging. This product has significantly diminished the pain in my knee and strengthened my bones. I noticed an impressive improvement after completing a course, as collagen is essential at any age. My knee no longer hurts.
Read More
7.5
Bone health benefits
The protein size is very good, and the dosage is once a week. It helps bolster immunity. The packaging is excellent, and it assists in reducing deficiency. It's beneficial for bone health and is easily absorbed. The quality and composition are excellent, providing much benefit.
Read More
Frequently Asked Questions
9
Knee pain alleviated
Excellent! The quality is superb, and the ingredients are harmoniously selected. I appreciate the taste and health benefits, along with the effective packaging. This product has significantly diminished the pain in my knee and strengthened my bones. I noticed an impressive improvement after completing a course, as collagen is essential at any age. My knee no longer hurts.
7.5
Bone health benefits
The protein size is very good, and the dosage is once a week. It helps bolster immunity. The packaging is excellent, and it assists in reducing deficiency. It's beneficial for bone health and is easily absorbed. The quality and composition are excellent, providing much benefit.
9
No more stomach pains
Sweet, I heard that whey protein is better absorbed, so I'm drinking this. Both my child and I experience bloated stomachs when we consume WPA protein; therefore, we use WPI with this ingredient. I no longer suffer from stomach pains due to its formulation.
8
We explored a unique case where a 39-year-old man presented with severe bone pain due to Sjögren's syndrome-related renal issues. He also exhibited symptoms like polydipsia and hypophosphatemic osteomalacia. After one month of potassium, phosphate, vitamin D, and sodium bicarbonate supplements, we observed significant relief in his bone pain, alongside normalized potassium and phosphorus levels. This indicates that potassium intake can play a crucial role in alleviating bone pain linked to kidney dysfunction in autoimmune conditions, such as Sjögren's syndrome.
8
We examined the effects of low-dose adefovir therapy on bone pain in patients showing signs of nephrogenic hypophosphatemic osteomalacia. Over two years, five patients developed reduced phosphate levels and renal issues, leading to bone pain. After stopping the treatment and providing phosphate and potassium supplements, we noticed significant decreases in bone pain and improved mobility in some patients. This indicates that potassium treatment, alongside phosphate supplementation, can positively affect bone pain related to kidney issues stemming from adefovir.
8
We explored the impact of calcium treatment on bone pain in patients who developed osteomalacia, a condition linked to intravenous iron infusions. Our focus was on a group of 13 patients diagnosed with this condition, who experienced low phosphate levels due to excess fibroblast growth factor 23 (iFGF23) after receiving ferric carboxymaltose (FCM) infusions.
After halting the FCM infusions, these patients were given supportive treatment, which included phosphate, calcium, and active Vitamin D supplementation. We observed improvements in biochemical markers, including increased phosphate levels and reduced pain scores. However, it’s important to note that while calcium was part of the treatment regimen, we could not isolate its specific effects on bone pain from the other supportive measures used.
Ultimately, our findings highlight the importance of monitoring phosphate levels in patients receiving FCM, and stopping these infusions effectively addresses phosphate wasting. Although supportive treatment showed improvements in pain and bone density, the direct impact of calcium on bone pain remains unclear given the combination of treatments involved.
After halting the FCM infusions, these patients were given supportive treatment, which included phosphate, calcium, and active Vitamin D supplementation. We observed improvements in biochemical markers, including increased phosphate levels and reduced pain scores. However, it’s important to note that while calcium was part of the treatment regimen, we could not isolate its specific effects on bone pain from the other supportive measures used.
Ultimately, our findings highlight the importance of monitoring phosphate levels in patients receiving FCM, and stopping these infusions effectively addresses phosphate wasting. Although supportive treatment showed improvements in pain and bone density, the direct impact of calcium on bone pain remains unclear given the combination of treatments involved.
References
- von Brackel FN, Grambeck J, Barvencik F, Amling M, Oheim R. In-depth clinical characterization of intravenous iron infusion-induced hypophosphatemic osteomalacia and its resolution. JBMR Plus. 2024;8:ziae139. doi:10.1093/jbmrpl/ziae139
- Chen R, Fang L, Fang X, Ning J. Sjögren's syndrome complicated with hypothyroidism and osteomalacia: A case report. Medicine (Baltimore). 2024;103:e39771. doi:10.1097/MD.0000000000039771
- Delanne-Cuménal M, Lamoine S, Meleine M, Aissouni Y, Prival L, et al. The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain. Biomed Pharmacother. 2024;176:116887. doi:10.1016/j.biopha.2024.116887
- Filler G, Schott C, Salerno FR, Ens A, McIntyre CW, et al. Growth hormone therapy in HHRH. Bone Rep. 2022;16:101591. doi:10.1016/j.bonr.2022.101591
- Geng Y, Zhao Y, Zhang Z. Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren's syndrome: a case report and review of the literature. Clin Rheumatol. 2018;37:257. doi:10.1007/s10067-017-3762-y
- Xu Y, Shen P, Pan X, Chen N. Nephrogenic hypophosphatemic osteomalacia during adefovir monotherapy for chronic hepatitis B monoinfection. Clin Kidney J. 2013;6:379. doi:10.1093/ckj/sft069
- Earle KE, Seneviratne T, Shaker J, Shoback D. Fanconi's syndrome in HIV+ adults: report of three cases and literature review. J Bone Miner Res. 2004;19:714.
